Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394940 · ClinicalTrials.gov registry record
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by University of Arizona.
- Completed
- Registry status
- 2,085
- Enrollment target
- 1
- Study location
NCT00394940: Completed study of Chronic Obstructive Pulmonary Disease, sponsored by University of Arizona.
NCT00394940 is a study of Chronic Obstructive Pulmonary Disease that has completed, run by University of Arizona. The registered enrollment target is 2,085 participants, above the 1,730-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394940, a study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 2,085 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent COPD develops. This study will use data collected during the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) and its 33-year follow-up to determine the relationship between inflammatory protein expression and COPD.
Conditions Studied
Study Locations (1)
Arizona
- Arizona Respiratory Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,085 participants |
| Start Date | 2006-07 |
| Est. Completion | 2013-01 |
What the finished NCT00394940 record still lists
NCT00394940 is an observational study that tracks outcomes without assigning an intervention. Its 2,085 participants enrollment target places it among the larger protocols in the corpus, above the 1,730-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (21% higher).
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00394940 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00394940 about?
NCT00394940 is a clinical study titled "Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease". Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent COPD develops. This study will use data collected during the Tucson Epidemiological Study of Airway Ob...
What is the current status of trial NCT00394940?
This trial is currently completed. The enrollment target is 2,085 participants. The study started on 2006-07. Estimated completion is 2013-01.
What conditions does trial NCT00394940 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
Who is sponsoring clinical trial NCT00394940?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00394940 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00394940's enrollment target sits among peer trials
2,085 7th of 86 higher than 80 of 86 other Chronic Obstructive Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373564 · 2,076 participants · Phase 4
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia